Cited by 1,163Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismParaoxonase enzyme and polymorphisms

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

Open access

Stampfer, Meir J., Sacks, Frank M., Salvini, Simonetta, Willett, Walter C., Hennekens, Charles H.·1991·New England Journal of Medicine

DOI 10.1056/nejm199108083250601

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The independent contributions of subfractions of high-density lipoprotein (HDL) cholesterol (HDL2 and HDL3) and apolipoproteins in predicting the risk of myocardial infarction are unclear. Prospective data are sparse, but HDL2 is widely believed to be a more important predictor than HDL3. METHODS: Blood samples were collected at base line from 14,916 men (ages, 40 to 84 years) who were participants in the Physicians' Health Study. After five years of follow-up, plasma samples from 246 men with new myocardial infarction (case subjects) were analyzed together with specimens from 246 men matched to them for age and smoking status who had not had a myocardial infarction. RESULTS: The levels of total cholesterol and apolipoprotein B-100 were significantly associated with an increased risk of myocardial infarction (data on levels of low-density lipoprotein cholesterol were unavailable). Both HDL cholesterol and HDL2 levels were associated with a substantially decreased risk of myocardial infarction, but the HDL3 level was the strongest predictor; the relative risk was 0.3 (95 percent confidence interval, 0.2 to 0.6) for those in the fifth of the group with the highest HDL3 levels, as compared with the fifth with the lowest levels. The benefit of a higher HDL cholesterol level was most pronounced among those with lower total cholesterol levels. Levels of apolipoprotein A-I and apolipoprotein A-II were also associated with decreased risk. However, the levels of HDL subfractions and apolipoproteins did not add significantly to the value of a multivariate model that included the ratio of total to HDL cholesterol in predicting myocardial infarction, whereas that ratio remained a significant independent predictor of risk. After adjustment for other risk factors, a change of one unit in the ratio of total to HDL cholesterol was associated with a 53 percent change in risk (95 percent confidence interval, 26 percent to 85 percent). CONCLUSIONS: This study underscores the importance of HDL cholesterol in predicting the risk of myocardial infarction and demonstrates protective effects of both the HDL3 and HDL2 subfractions of HDL cholesterol. We found little or no predictive value for the levels of apolipoproteins A-I, A-II, and B or HDL subfractions after conventional risk factors and the ratio of total to HDL cholesterol were considered.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199108083250601

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

From the New York Times Magazine
Minsky, & Hyman, P. (1979) · Cited by 6,899
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
THE TROMSØHEART-STUDY
Miller, N. E., Thelle, D. S., Førde, O. H., & Mjøs, O. D. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92274-7 · Cited by 1,206
Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure
Gidez, L. I., Miller, G. J., Burstein, M., Slagle, S., & Eder, H. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38059-7 · Cited by 757
Ischemic Heart Disease, Atherosclerosis, and Longevity
Gofman, J. W., Young, W., & Tandy, R. K. (1966) · Circulation · doi:10.1161/01.cir.34.4.679 · Cited by 587
Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery Disease
Maciejko, J. J., Holmes, D. R., Kottke, B. A., Zinsmeister, A. R., Dinh, D. M., & Mao, S. J. T. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090701 · Cited by 537
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel
Goodman, D. S., Hulley, S. B., Clark, L. T., Davis, C. E., Fuster, V., LaRosa, J. C., Oberman, A., Schaefer, E. J., Steinberg, D., Brown, W. V., et al. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.1.36 · Cited by 529
ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS?
Avogaro, P., Bon, G. B., Avogaro, P., Cazzolato, G., & Quinci, G. B. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91375-8 · Cited by 523

Show all 56 references

Research works printed but not linked: 10

Enger, 1979, Artery, 5, 170
Bennett, 1988, New York Times Magazine, 55
Jones PH, Gotto AM Jr. Assessment of lipid abnormalities. In: Hurst JW, Schlant RC, Rachley CE, Sonnenblick EH, Wenger NK, eds. The heart: arteries and veins. 7th ed. New York: McGraw-Hill, 1990:378–84.
10.1001/archinte.150.8.1645 · DOI
Musliner, 1988, Clin Chem, 34, B78
Hennekens, 1987, Circulation, 76, IV-501
Kempen, 1987, J Lab Clin Med, 109, 19
Avogaro P, Cazzolato G, Bittolo Bon G, Rorai E, Pontoglio E. Lipoprotein derangements in human atherosclerosis. In: Noseda G, Fragiacomo C, Fumagalli R, Paoletti R, eds. Lipoproteins and coronary atherosclerosis. Amsterdam: Elsevier, 1982:123–42.
Kladetzky, 1980, Artery, 7, 191
Desager JP, Rousseau M, Riesen WF, Harvengt C. Limitations of the predictive value for coronary vascular disease of plasma lipids and apoproteins AI, AII, B levels as measured before coronarography in 317 patients. In: de Gennes JL, Polonovski J, Paoletti R, eds. Latent dyslipoproteinemias and atherosclerosis. New York: Raven Press, 1984:165–74.

Sorted by citations

Items 301–400 of 999

Should low high-density lipoprotein cholesterol (HDL-C) be treated?
Toth, P. P., Barylski, M., Nikolić, D., Rizzo, M., Montalto, G., & Banach, M. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.11.002 · Cited by 67
Alcohol, Type of Alcohol, and All‐Cause and Coronary Heart Disease Mortality
Grønbæk, M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02902.x · Cited by 68
Systemic Inflammation as a Cardiovascular Disease Risk Factor and as a Potential Target for Drug Therapy
Kaplan, R. C., & Frishman, W. H. (2001) · Heart Disease · doi:10.1097/00132580-200109000-00009 · Cited by 67
Dietary Restriction of Saturated Fat and Cholesterol Decreases HDL ApoA-I Secretion
Velez‐Carrasco, W., Lichtenstein, A. H., Welty, F. K., Li, Z., Lamon‐Fava, S., Dolnikowski, G. G., & Schaefer, E. J. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.4.918 · Cited by 67
Atherogenic indices in stroke patients: A retrospective study.
Rajaragupathy, S., & Kavitha, S. (2017) · PubMed Central · Cited by 66
Coronary artery disease in patients at low risk — apolipoprotein AI as an independent risk factor
Francis, M. C., & Frohlich, J. J. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00528-1 · Cited by 66
Trans-fatty acids induce pro-inflammatory responses and endothelial cell dysfunction
Harvey, K. A., Arnold, T. S., Rasool, T., Antalis, C. J., Miller, S. J., & Siddiqui, R. A. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507842772 · Cited by 65
Evidence for linkage of the apolipoprotein A-II locus to plasma apolipoprotein A-II and free fatty acid levels in mice and humans.
Warden, C. H., Daluiski, A., Bu, X., Purcell-huynh, D. A., Meester, C. D., Shieh, B., Puppione, D. L., Gray, R. M., Reaven, G. M., & Chen, Y. I. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10886 · Cited by 65
Food and Western Disease Health and Nutrition from an Evolutionary Perspective
Lindeberg, S. (2009) · Cited by 64
Coronary artery disease: the role of lipids, hypertension and smoking
Keil, U. (2000) · Basic Research in Cardiology · doi:10.1007/s003950070010 · Cited by 64
Butter, margarine and serum lipoproteins
Zock, P. L. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06063-7 · Cited by 64
HDLs Containing Apolipoproteins A-I and A-II (LpA-I:A-II) as Markers of Coronary Artery Disease in Men With Non–Insulin- Dependent Diabetes Mellitus
Syvänne, M., Kahri, J., Virtanen, K. S., & Taskinen, M. (1995) · Circulation · doi:10.1161/01.cir.92.3.364 · Cited by 64
Ethanol stimulates apolipoprotein A-I secretion by human hepatocytes: Implications for a mechanism for atherosclerosis protection
Amarasuriya, R. N., Gupta, A., Civen, M., Horng, Y.-C., MAEDA, T., & Kashyap, M. L. (1992) · Metabolism · doi:10.1016/0026-0495(92)90162-4 · Cited by 64
Apolipoprotein A-I and B and Stroke Events in a Community-Based Cohort in Taiwan
Chien, K., Sung, F., Hsu, H., Su, T., Lin, R. S., & Lee, Y. (2002) · Stroke · doi:10.1161/hs0102.101626 · Cited by 63
ApoA1 Reduces Free Cholesterol Accumulation in Atherosclerotic Lesions of ApoE–Deficient Mice Transplanted With ApoE–Expressing Macrophages
Boisvert, W. A., Black, A. S., & Curtiss, L. K. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.3.525 · Cited by 64
VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice
VanderLaan, P. A., Reardon, C. A., Thisted, R. A., & Getz, G. S. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800284-jlr200 · Cited by 62
Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling
Perera, R., McFadden, E. C., McLellan, J., Lung, T. W.-C., Clarke, P., Pérez, T., Fanshawe, T. R., Dalton, A., Farmer, A. A., Glasziou, P., et al. (2015) · Health Technology Assessment · doi:10.3310/hta191000 · Cited by 63
Psychophysiological reactions during the first year of a foreign assignment: Results of a controlled longitudinal study
Anderzén, I., & Arnetz, B. B. (1997) · Work & Stress · doi:10.1080/02678379708252994 · Cited by 62
Metabolic and Immune Activation Effects of Treatment Interruption in Chronic HIV-1 Infection: Implications for Cardiovascular Risk
Tebas, P., Henry, K., Matining, R. M., Cherng, D. W., Schmitz, J. L., Valdez, H., Jahed, N. C., Myers, L., Powderly, W. G., & Katzenstein, D. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002021 · Cited by 61
Detrimental Impact of Trans Fats on Human Health: Stearic Acid‐Rich Fats as Possible Substitutes
Crupkin, M., & Zambelli, A. (2008) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/j.1541-4337.2008.00045.x · Cited by 71
AGE-BSA decreases ABCG1 expression and reduces macrophage cholesterol efflux to HDL
Isoda, K., Folco, E. J. E., Shimizu, K., & Libby, P. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.07.023 · Cited by 61
Advances in understanding of the role of lecithin cholesterol acyltransferase (LCAT) in cholesterol transport
Dobiášová, M., & Frohlich, J. J. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00106-0 · Cited by 61
Unusual high-density lipoprotein subclass distribution during late pregnancy
Silliman, K., Tall, A. R., Kretchmer, N., & Forte, T. M. (1993) · Metabolism · doi:10.1016/0026-0495(93)90156-i · Cited by 61
Metabolic syndrome: Evaluation of pathological and therapeutic outcomes
Miranda, P. J., DeFronzo, R. A., Califf, R. M., & Guyton, J. R. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.07.012 · Cited by 61
Effect of alcohol consumption on endothelial function in men with coronary artery disease
Teragawa, H., Fukuda, Y., Matsuda, K., Higashi, Y., Yamagata, T., Matsuura, H., & Chayama, K. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00193-4 · Cited by 60
Long-term effects of weight reduction on serum lipids and plasma insulin in obese children
Knip, M., & Nuutinen, O. (1993) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/57.4.490 · Cited by 61
Effects of Ocular Carteolol and Timolol on Plasma High-density Lipoprotein Cholesterol Level
Freedman, S. F., Freedman, N. J., Shields, M. B., Lobaugh, B., Samsa, G. P., Keates, E. U., & Ollie, A. R. (1993) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)73203-9 · Cited by 61
Familial HDL Deficiency Characterized by Hypercatabolism of Mature ApoA-I but Not ProApoA-I
Batal, R., Tremblay, M., Krimbou, L., Mamer, O., Davignon, J., Genest, J. J., & Cohn, J. S. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.4.655 · Cited by 61
Role of genetic variation at the Apo AI‐CIII‐AIV gene cluster in determining plasma Apo AI levels in boys and girls
Xu, C., Angelico, F., Ben, M. D., & Humphries, S. E. (1993) · Genetic Epidemiology · doi:10.1002/gepi.1370100204 · Cited by 61
Lipid, lipoprotein, and apolipoprotein profiles in active and sedentary men with tetraplegia
Dallmeijer, A. J., Hopman, M. T. E., & van der Woude, L. H. V. (1997) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/s0003-9993(97)90327-0 · Cited by 60
Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review
Chirovsky, D. R., Fedirko, V., Cui, Y. A., Sazonov, V., & Barter, P. J. (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32832c8891 · Cited by 58
Secular trends in cholesterol lipoproteins and triglycerides and prevalence of dyslipidemias in an urban Indian population
Gupta, R., Guptha, S., Agrawal, A., Kaul, V., Gaur, K., & Gupta, V. P. (2008) · Lipids in Health and Disease · doi:10.1186/1476-511x-7-40 · Cited by 59
Lignans from the Fruits ofForsythia suspensa(Thunb.) Vahl Protect High-Density Lipoprotein during Oxidative Stress
Chang, M., Hưng, T. M., Byung-Sun, M. I. N., Kim, J., Woo, M. H., Choi, J. S., Lee, H. K., & Bae, K. (2008) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.80392 · Cited by 59
Relation of Low‐Density Lipoprotein Cholesterol With Microvascular Injury and Clinical Outcome in Revascularized ST‐Elevation Myocardial Infarction
Reindl, M., Reinstadler, S. J., Feistritzer, H., Theurl, M., Basic, D., Eigler, C., Holzknecht, M., Mair, J. M., Mayr, A., Klug, G., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006957 · Cited by 59
Differential Effect of National Cholesterol Education Program (NCEP) Step II Diet on HDL Cholesterol, Its Subfractions, and Apoprotein A-I Levels in Hypercholesterolemic Women and Men After 1 Year
Walden, C. E., Retzlaff, B. M., Buck, B. L., Wallick, S., McCann, B. S., & Knopp, R. H. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1580 · Cited by 59
High density lipoprotein cholesterol increases with living altitude
Coello, S. D. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.1.65 · Cited by 59
Effect of Oral Estradiol on Lp(a) and Other Lipoproteins in Postmenopausal Women
Haines, C. J. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440080060007 · Cited by 59
A unique genetic and biochemical presentation of fish-eye disease.
Kuivenhoven, J. A., Voorst, E. V. V. T., Wiebusch, H., Marcovina, S. M., Funke, H., Assmann, G., Pritchard, P. H., & Kastelein, J. J. P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118348 · Cited by 58
HDL in atherosclerosis: actor or bystander?
Asztalos, B. F., & Schaefer, E. J. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00006-0 · Cited by 59
Atherogenic Lipids and Lipoproteins in Hemodialysis Patients
Cheung, A. K., Wu, L., Kablitz, C., & Leypoldt, J. K. (1993) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70318-9 · Cited by 58
Familial clustering of obesity and breast cancer
Parent, M., Ghadirian, P., & Lacroix, A. (1996) · Genetic Epidemiology · doi:10.1002/(sici)1098-2272(1996)13:1 · Cited by 9
Long-term (5-Year) Changes in HDL Cholesterol in Cardiac Rehabilitation Patients
Warner, J. G., Brubaker, P. H., Zhu, Y. Y., Morgan, T. M., Ribisl, P. M., Miller, H. S., & Herrington, D. M. (1995) · Circulation · doi:10.1161/01.cir.92.4.773 · Cited by 58
Polymorphisms at the 5'-end of the apolipoprotein AI gene and severity of coronary artery disease.
Wang, X. L., Liu, S. X., McCredie, R. M., & Wilcken, D. E. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118802 · Cited by 58
Plasma lipid profiles and epidemiology of atherosclerotic diseases in Taiwan — a unique experience
Pan, W., & Chiang, B. N. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05616-5 · Cited by 58
Protein-Defined Subspecies of HDLs (High-Density Lipoproteins) and Differential Risk of Coronary Heart Disease in 4 Prospective Studies
Sacks, F. M., Liang, L., Furtado, J. D., Cai, T., Davidson, W. S., He, Z., McClelland, R. L., Rimm, E. B., & Jensen, M. K. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314609 · Cited by 57
Self-citation
Magnoflorine from Coptidis Rhizoma Protects High Density Lipoprotein during Oxidant Stress
Hưng, T. M., Lee, J., Min, B. S., Choi, J. S., Na, M., Zhang, X., Ngoc, T. M., Lee, I., & Bae, K. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.1157 · Cited by 57
The association of interleukin-18 genotype and serum levels with metabolic risk factors for cardiovascular disease
Evans, J., Collins, M., Jennings, C., van der Merwe, L., Söderström, I., Olsson, T., Levitt, N. S., Lambert, E. V., & Goedecke, J. H. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0463 · Cited by 57
The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better
Peters, M. J. L., Voskuyl, A. E., Sattar, N. A., Dijkmans, B. A. C., Smulders, Y. M., & Nurmohamed, M. T. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02220.x · Cited by 56
A 16-week fenofibrate treatment increases LDL particle size in type IIA dyslipidemic patients.
Lemieux, I., Laperrière, L., Džavík, V., Tremblay, G., Bourgeois, J., & Despres, J. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00711-0 · Cited by 63
Abnormal HDL Apolipoprotein A-I and A-II Kinetics in Hemodialysis Patients
Okubo, K., Ikewaki, K., Sakai, S., Tada, N., Kawaguchi, Y., & Mochizuki, S. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000117286.85443.7d · Cited by 56
The Effect of Concurrent Training on Blood Lipid Profile and Anthropometrical Characteristics of Previously Untrained Men
Ghahramanloo, E., Midgley, A. W., & Bentley, D. J. (2009) · Journal of Physical Activity and Health · doi:10.1123/jpah.6.6.760 · Cited by 55
A Solid Dietary Fat Containing Fish Oil Redistributes Lipoprotein Subclasses without Increasing Oxidative Stress in Men
Tholstrup, T., Hellgren, L. I., Petersen, M., Basu, S., Straarup, E. M., Schnohr, P., & Sandström, B. (2004) · Journal of Nutrition · doi:10.1093/jn/134.5.1051 · Cited by 55
High density lipoprotein subfractions and the risk of coronary heart disease: 9-years follow-up in the Caerphilly Study
Yu, S., YARNELL, J. W. G., Sweetnam, P. M., & Bolton, C. H. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00361-1 · Cited by 55
Fat Distribution and Metabolic Abnormalities in HIV-Infected Patients on First Combination Antiretroviral Therapy Including Stavudine or Zidovudine: Role of Physical Activity as a Protective Factor
Domingo, P., Sambeat, M. A., Pérez, A., Ordóñez‐Llanos, J., Rodrı́guez-Espinosa, J., & Vázquez-Mata, G. (2003) · Antiviral Therapy · doi:10.1177/135965350300800306 · Cited by 54
Effect of apolipoprotein e polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients
Güz, G., Özdemir, F. N., Sezer, S., Işıklar, I., Arat, Z., Turan, M., & Haberal, M. A. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.17682 · Cited by 55
Changes in lipid, lipoprotein and apolipoprotein profiles in persons with spinal cord injuries during the first 2 years post-injury
Dallmeijer, A. J., van der Woude, L. H. V., van Kamp, G. J., & Hollander, A. P. (1999) · Spinal Cord · doi:10.1038/sj.sc.3100776 · Cited by 55
Structural and functional differences of subspecies of apoA-I-containing lipoprotein in patients with plasma cholesteryl ester transfer protein deficiency.
Ohta, T., Nakamura, R., Takata, K., Saito, Y., Yamashita, S., Horiuchi, S., & Matsuda, I. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40055-0 · Cited by 55
Increased production of apolipoprotein A-I associated with elevated plasma levels of high-density lipoproteins, apolipoprotein A-I, and lipoprotein A-I in a patient with familial hyperalphalipoproteinemia
Rader, D. J., Schaefer, J. R., Lohse, P., Ikewaki, K., Fairwell, T., Harris, W. A., Zech, L. A., Dujovne, C. A., & Brewer, H. B. (1993) · Metabolism · doi:10.1016/0026-0495(93)90194-s · Cited by 55
Quantity and function of high density lipoprotein as an indicator of coronary atherosclerosis
Saku, K., Zhang, B., Ohta, T., & Arakawa, K. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00560-9 · Cited by 55
Guanidine to adenine (G/A) substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI levels in chinese non‐smokers
Saha, N., Tay, J. S. H., Low, P., & Humphries, S. E. (1994) · Genetic Epidemiology · doi:10.1002/gepi.1370110304 · Cited by 54
Impact of Nevirapine on Lipid Metabolism
Clotet, B., van der Valk, M., Negredo, E., & Reiss, P. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200309011-00012 · Cited by 53
Combined effect of vegetable protein (soy) and soluble fiber added to a standard cholesterol-lowering diet
Jenkins, D. J. A., Kendall, C. W. C., Mehling, C. C., Parker, T. L., Rao, A. V., Agarwal, S., Novokmet, R., Jones, P. J. H., Raeini, M., Story, J. A., et al. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90184-1 · Cited by 52
Omega-6 polyunsaturated fatty acids and coronary heart disease
Katan, M. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27744 · Cited by 54
Culture and Healthy Eating: The Role of Independence and Interdependence in the United States and Japan
Levine, C. S., Miyamoto, Y., Markus, H. R., Rigotti, A., Boylan, J. M., Park, J., Kitayama, S., Karasawa, M., Kawakami, N., Coe, C. L., et al. (2016) · Personality and Social Psychology Bulletin · doi:10.1177/0146167216658645 · Cited by 53
A comparison of the effect of free access to reduced fat products or their full fat equivalents on food intake, body weight, blood lipids and fat-soluble antioxidants levels and haemostasis variables
Weststrate, J., Hof, K. H. V. H., van den Berg, H., Wierik, E. J. M. V.-T., de Graaf, C., Zimmermanns, N., Westerterp, K. R., Westerterp‐Plantenga, M. S., & de Venne, W. P. H. G. V. (1998) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600570 · Cited by 53
Evaluation of effects of unmodified niacin on fasting and postprandial plasma lipids in normolipidemic men with hypoalphalipoproteinemia
King, J. M., Crouse, J. R., Terry, J. G., Morgan, T. M., Spray, B. J., & Miller, N. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90298-4 · Cited by 53
Dietarytransα-linolenic acid from deodorised rapeseed oil and plasma lipids and lipoproteins in healthy men: theTransLinE Study
Vermunt, S. H. F., Beaufrère, B., Riemersma, R. A., Sébédio, J., Chardigny, J., & Mensink, R. P. (2001) · British Journal Of Nutrition · doi:10.1079/bjn2000270 · Cited by 52
Plasma Phospholipid Trans ‐Fatty Acids Levels, Cardiovascular Diseases, and Total Mortality: The Cardiovascular Health Study
Wang, Q., Imamura, F., Lemaître, R. N., Rimm, E. B., Wang, M., King, I. B., Song, X., Siscovick, D. S., & Mozaffarian, D. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.000914 · Cited by 53
17β-Estradiol Inhibits PCSK9-Mediated LDLR Degradation Through GPER/PLC Activation in HepG2 Cells
Fu, W., Gao, X., Zhang, S., Dai, Y., Zou, W., & Yue, L.-M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00930 · Cited by 51
Serum lipoproteins in acromegaly before and 6‐15 months after transsphenoidal adenomectomy
Oscarsson, J., Wiklund, O., Jakobsson, K. E., Petruson, B., & Bengtsson, B. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb01825.x · Cited by 52
Commentary: alcohol, the heart, and public policy.
Stampfer, M. J., Rimm, E. B., & Walsh, D. C. (1993) · American Journal of Public Health · doi:10.2105/ajph.83.6.801 · Cited by 52
Self-citation
The Role of High-Density Lipoprotein Cholesterol in 2022
Sirtori, C. R., Corsini, A., & Ruscica, M. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01012-y · Cited by 55
The relationship between high density lipoprotein subclass profile and plasma lipids concentrations
Tian, L., & Fu, M. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-118 · Cited by 53
Dyslipidemia Profiles in Patients with Peripheral Artery Disease
Aday, A. W., & Everett, B. M. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1129-5 · Cited by 51
Effect of alcohol and exercise on postprandial lipemia and triglyceride clearance in men
Hartung, G. H., Lawrence, S. J., Reeves, R. S., & Foreyt, J. P. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90065-3 · Cited by 51
Association of endothelial lipase gene (LIPG) haplotypes with high-density lipoprotein cholesterol subfractions and apolipoprotein AI plasma levels in Japanese Americans
Hutter, C. M., Austin, M. A., Farin, F. M., Viernes, H.-M. A., Edwards, K. L., Leonetti, D. L., McNeely, M. J., & Fujimoto, W. Y. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.05.033 · Cited by 51
Marked benefit with sustained-release niacin therapy in patients with “isolated” very low levels of high-density lipoprotein cholesterol and coronary artery disease
Lavie, C. J., Mailander, L., & Milani, R. V. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90868-y · Cited by 51
High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene.
Lackner, K. J., Dieplinger, H., Nowicka, G., & Schmitz, G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116830 · Cited by 51
High-density lipoprotein metabolism and progression of atherosclerosis: new insights from the HDL Atherosclerosis Treatment Study
Asztalos, B. F. (2004) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000126979.41946.7e · Cited by 51
Patient-Level Discordance in Population Percentiles of the Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Comparison With Low-Density Lipoprotein Cholesterol and Non–High-Density Lipoprotein Cholesterol
Elshazly, M. B., Quispe, R., Michos, E. D., Sniderman, A. D., Toth, P. P., Banach, M., Kulkarni, K. R., Coresh, J., Blumenthal, R. S., Jones, S. R., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.016163 · Cited by 50
Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease
Estrada-Luna, D., Ortiz-Rodríguez, M. A., Medina-Briseño, L., Carreón‐Torres, E., Vega, J. A. I., Sharma, A. K., Cancino‐Díaz, J. C., Pérez-Méndez, O. A., Belefant‐Miller, H., & Cabrera, G. B. (2018) · Molecules · doi:10.3390/molecules23112730 · Cited by 51
Excess coronary artery disease risk in South Asian immigrants: Can dysfunctional high-density lipoprotein explain increased risk?
Dodani, S. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s2915 · Cited by 49
Serum Lipid Concentrations and Prevalence of Dyslipidemia in a Large Professional Population in Beijing
Li, Z., Yang, R., Xu, G., & Xia, T. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.038646 · Cited by 51
Effect of gemfibrozil in men with primary isolated low high-density lipoprotein cholesterol: A randomized, double-blind, placebo-controlled, crossover study
Miller, M. J., Bachorik, P. S., McCrindle, B. W., & Kwiterovich, P. O. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90113-4 · Cited by 50
Apolipoproteins A–I, A–II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly Study
Sweetnam, P. M., Bolton, C., Downs, L. G., Durrington, P. N., Mackness, M., Elwood, P. C., & Yarnell, J. W. G. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00725.x · Cited by 50
The Effect of Hormone Replacement Therapy and Exercise on Cardiovascular Disease Risk Factors in Postmenopausal Women
Haddock, B. L., Marshak, H. P. H., Mason, J. J., & Blix, G. (2000) · Sports Medicine · doi:10.2165/00007256-200029010-00004 · Cited by 49
Identifying Adults at Low Risk for Significant Hyperlipidemia A Validated Clinical Index
Grover, S. A. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00139-5 · Cited by 49
Menopausal Hormone Therapy
Bhavnani, B. R., & Strickler, R. C. (2005) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)30186-4 · Cited by 49
No effect of glucagon-like peptide-1 on short-term satiety and energy intake in man
Long, S. J., Sutton, J. A., Amaee, W., Giouvanoudi, A., Spyrou, N. M., Rogers, P. J., & Morgan, L. (1999) · British Journal Of Nutrition · doi:10.1017/s0007114599000513 · Cited by 49
Apolipoprotein A1 and B
Sniderman, A. D., & Marcovina, S. M. (2006) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2006.07.007 · Cited by 49
Reduction of phosphatidylcholine hydroperoxide by apolipoprotein A-I: purification of the hydroperoxide-reducing proteins from human blood plasma
Mashima, R., Yamamoto, Y., & Yoshimura, S. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32537-2 · Cited by 49
ApoA-IHelsinki(Lys107→0) Associated With Reduced HDL Cholesterol and LpA-I:A-II Deficiency
Tilly-Kiesi, M., Qiu-ping, Z., Ehnholm, S., Kahri, J., Lahdenperä, S., Ehnholm, C., & Taskinen, M. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.9.1294 · Cited by 48
Apolipoprotein A-I metabolism in cholesteryl ester transfer protein transgenic mice. Insights into the mechanisms responsible for low plasma high density lipoprotein levels.
Melchior, G. W., Castle, C. K., Murray, R. W., Blake, W. L., Dinh, D. M., & Marotti, K. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37157-0 · Cited by 48
Nonalcoholic fatty liver disease and the heart in children and adolescents.
Pacifico, L., Chiesa, C., Anania, C., Merulis, A. D., Osborn, J. F., Romaggioli, S., & Gaudio, E. (2014) · PubMed · doi:10.3748/wjg.v20.i27.9055 · Cited by 46
Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease
Bakogianni, M., Kalofoutis, C. A., Skenderi, K. I., & Kalofoutis, A. (2001) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00159-3 · Cited by 47
31st G. Heiner Sell Lectureship: Secondary Medical Consequences of Spinal Cord Injury
Bauman, W. A., Korsten, M. A., Radulovic, M., Schilero, G. J., Wech, J., & Spungen, A. M. (2012) · Topics in Spinal Cord Injury Rehabilitation · doi:10.1310/sci1804-354 · Cited by 47
Cholesterol-Lowering Effects oHypercholesterolemiain Patients With Mild to Moderate Hypercholesterolemia
Bell, L. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400240061010 · Cited by 47
Clinical significance of lipoprotein size and risk for coronary atherosclerosis
Roheim, P. S., & Asztalos, B. F. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.1.147 · Cited by 47
Saturated fatty acid (SFA) status and SFA intake exhibit different relations with serum total cholesterol and lipoprotein cholesterol: a mechanistic explanation centered around lifestyle-induced low-grade inflammation
Ruiz-Núñez, B., Kuipers, R. S., Luxwolda, M. F., Graaf, D. J. D., Breeuwsma, B. B., Dijck-Brouwer, J., & Muskiet, F. A. J. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.11.004 · Cited by 47
Exercise training does not reduce hyperlipidemia in pigs fed a high-fat diet
Thomas, T. R., Pellechia, J., Rector, R. S., Sun, G. Y., Sturek, M. S., & Laughlin, M. H. (2002) · Metabolism · doi:10.1053/meta.2002.36313 · Cited by 46

Authors: Stampfer, M. J., Sacks, F. M., Salvini, S., Willett, W. C., & Hennekens, C. H.
Affiliations: Brigham and Women's Hospital (US)
ORCID: Stampfer, Meir J.
Sacks, Frank M.
Willett, Walter C.
Hennekens, Charles H.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1991-08-08
Volume: 325
Issue: 6
Pages: 373-381
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199108083250601
OpenAlex: W2337032743
Cited by: 1,163
References: 56
Citations by year: 2026: 6 · 2025: 5 · 2024: 10 · 2023: 10 · 2022: 7 · 2021: 12 · 2020: 14 · 2019: 12 · 2018: 18 · 2017: 17 · 2016: 24 · 2015: 31 · 2014: 34 · 2013: 33 · 2012: 31
FWCI: 80.75
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (HL-34595, HL 26490, R01HL034595)
National Cancer Institute (R01CA042182, CA 42182)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords: myocardial infarction, HDL cholesterol, HDL2, HDL3, apolipoprotein B-100, apolipoprotein A-I, apolipoprotein A-II, TC/HDL-C ratio, cardiovascular risk prediction, total cholesterol, men, Physicians' Health Study, lipoprotein subfractions, risk factors, coronary heart disease prevention, statin therapy
MeSH terms: Adult, Aged, Aged, 80 and over, Apolipoproteins, Apolipoproteins A, Apolipoproteins B, Cholesterol, Humans, Cholesterol, HDL, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks